Lind, Lars
Kullberg, Joel
Ahlström, Håkan
Michaëlsson, Karl
Strand, Robin http://orcid.org/0000-0001-7764-1787
Funding for this research was provided by:
Vetenskapsrådet (2016-01040, 2016-01040)
Article History
Received: 9 May 2018
Accepted: 18 April 2019
First Online: 14 May 2019
Competing Interests
: Joel Kullberg and Håkan Ahlström are cofounders, co-owners of and employed at Antaros Medical AB, BioVenture Hub, Mölndal, Sweden. Antaros has not been involved in the development of Imiomics. However, we are currently considering collaborating on the Imiomics concept with Antaros Medical AB.